Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and …
Over the last 12 months, insiders at Tilray Brands, Inc. have bought $183,210 and sold $0 worth of Tilray Brands, Inc. stock.
On average, over the past 5 years, insiders at Tilray Brands, Inc. have bought $183,210 and sold $48.55M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SIMON IRWIN D (President and CEO) — $302,868. Gendel Mitchell (Global General Counsel) — $73,062. FALTISCHEK DENISE M (Chief Strategy Officer) — $41,000.
The last purchase of 10,000 shares for transaction amount of $20,500 was made by FALTISCHEK DENISE M (Chief Strategy Officer) on 2024‑01‑17.
2024-01-17 | Chief Strategy Officer | 10,000 0.0013% | $2.05 | $20,500 | -12.41% | |||
2024-01-16 | Global General Counsel | 7,200 0.0009% | $1.98 | $14,256 | -13.25% | |||
2024-01-12 | President and CEO | 53,700 0.0073% | $1.88 | $100,956 | -3.74% | |||
2024-01-12 | Global General Counsel | 5,400 0.0007% | $1.87 | $10,098 | -3.74% | |||
2024-01-12 | Chief Financial Officer | 20,000 0.0027% | $1.87 | $37,400 | -3.74% | |||
2022-11-07 | Sale | director | 350,000 0.0575% | $3.78 | $1.32M | -32.98% | ||
2022-10-05 | Sale | director | 350,000 0.0559% | $2.91 | $1.02M | |||
2022-09-06 | Sale | 350,000 0.0582% | $3.22 | $1.13M | -13.41% | |||
2022-08-05 | Sale | 350,000 0.061% | $3.91 | $1.37M | -27.69% | |||
2022-07-05 | Sale | 350,000 0.058% | $3.09 | $1.08M | -7.10% | |||
2021-08-05 | Sale | 600,000 0.1334% | $14.46 | $8.68M | -53.59% | |||
2021-08-04 | Sale | 600,000 0.1365% | $14.27 | $8.56M | -51.36% | |||
2021-07-16 | Sale | 600,000 0.1347% | $14.04 | $8.42M | -47.88% | |||
2021-07-15 | Sale | 600,000 0.136% | $14.67 | $8.8M | -49.55% | |||
2021-06-18 | Sale | 800,000 0.1809% | $17.19 | $13.75M | -51.86% | |||
2021-06-17 | Sale | 800,000 0.1791% | $17.58 | $14.06M | -53.41% | |||
2021-06-03 | Sale | 47,652 0.0106% | $19.64 | $935,885 | -51.62% | |||
2021-05-12 | Sale | 178,000 0.0407% | $14.82 | $2.64M | -27.74% | |||
2020-12-16 | Sale | director | 4,400 0.0015% | $10.00 | $44,000 | +57.13% | ||
2020-11-06 | Sale | President and CEO | 800,000 0.2825% | $9.88 | $7.91M | +52.75% |
SIMON IRWIN D | President and CEO | 2033058 0.2251% | $1.55 | 1 | 0 | |
FALTISCHEK DENISE M | Chief Strategy Officer | 293269 0.0325% | $1.55 | 1 | 0 | |
Gendel Mitchell | Global General Counsel | 195796 0.0217% | $1.55 | 2 | 0 | |
Merton Carl A | Chief Financial Officer | 20000 0.0022% | $1.55 | 1 | 1 | |
Kennedy Brendan | director | 6224196 0.6891% | $1.55 | 1 | 33 | +141.09% |